PSMA PET Scan in Delhi — Prostate Cancer Detection & Staging | Neurad Diagnostics

Prostate cancer is the second most common cancer in men worldwide, and in India it represents a growing health challenge. If you or someone you love has been diagnosed with prostate cancer — or if PSA levels are rising after treatment — your urologist or oncologist may recommend a PSMA PET Scan. Available at Neurad Diagnostics in Delhi, the 68Ga-PSMA PET/CT scan is the most advanced and accurate imaging technology for prostate cancer detection, staging, and monitoring available today. This comprehensive guide explains everything you need to know about this scan and why Neurad Diagnostics is the best choice in Delhi NCR.

What Is a the PSMA scan?

The this PET/CT, formally known as 68Ga-PSMA-11 PET/CT (or PSMA PET/CT), is a revolutionary nuclear medicine imaging study that uses a Gallium-68 labelled tracer targeting Prostate-Specific Membrane Antigen (PSMA) — a protein highly expressed on the surface of prostate cancer cells. When the tracer is injected into the bloodstream, it binds selectively to PSMA on prostate cancer cells throughout the body. The PET scanner detects the radioactive signal and creates detailed whole-body images showing exactly where prostate cancer cells are present — including primary tumor, lymph node involvement, bone metastases, and distant organ spread.

PSMA PET Scan represents a quantum leap in prostate cancer imaging. It was approved by the US FDA in 2020-2021 and has rapidly become the global standard for prostate cancer staging and restaging. The European Association of Nuclear Medicine (EANM), the American Urological Association (AUA), and leading oncology bodies worldwide now recommend PSMA PET/CT as first-line imaging for high-risk and recurrent prostate cancer.

Why Doctors Recommend the the procedure

Urologists, oncologists, and radiation oncologists recommend the this scan because it provides information that conventional imaging simply cannot match. Traditional CT scans and bone scans miss the majority of prostate cancer metastases, particularly at low PSA levels — leading to under-staging, incorrect treatment selection, and missed opportunities for curative intervention. The PSMA PET Scan solves this problem by detecting disease at the molecular level, revealing metastases that are invisible on other scans.

The clinical impact is profound: studies show that this imaging test changes treatment management in 50-70% of patients compared to conventional imaging. It allows surgeons to target the right lymph nodes, enables radiation oncologists to treat all sites of disease, and identifies patients suitable for the revolutionary Lu-177 PSMA therapy — a form of targeted nuclear medicine treatment for metastatic castration-resistant prostate cancer.

Diseases and Conditions Diagnosed by the PSMA scan

The PSMA PET Scan is used across multiple stages of prostate cancer management:

• Primary staging: Assessment of newly diagnosed high-risk or intermediate-risk prostate cancer before surgery or radiation
• Biochemical recurrence: Detection of disease recurrence when PSA rises after radical prostatectomy or radiotherapy
• Metastatic prostate cancer: Mapping the full extent of disease spread to lymph nodes, bones, and organs
• Treatment response monitoring: Evaluating response to androgen deprivation therapy, chemotherapy, or targeted treatments
• PSMA-targeted therapy selection: Confirming eligibility for Lu-177 PSMA-617 (Pluvicto) treatment
• Oligometastatic disease: Identifying limited metastases suitable for curative local treatment (metastasis-directed therapy)

Who Needs a this PET/CT?

Your doctor may recommend a the procedure in Delhi if you are in one of these situations:

• Newly diagnosed prostate cancer with high-risk features (PSA > 20, Gleason 8-10, or T3/T4 disease)
• Rising PSA after radical prostatectomy (even as low as 0.2 ng/mL)
• PSA rising after radiation therapy
• Known metastatic prostate cancer being re-staged
• Considering PSMA-targeted therapy (Lu-177 PSMA)
• Inconclusive findings on CT or bone scan
• Planning salvage lymph node dissection or salvage radiotherapy
• Monitoring response to systemic therapy

Symptoms That May Lead to PSMA PET Scan

While this scan is often ordered based on PSA levels or pathological findings rather than symptoms alone, the following clinical presentations may prompt your doctor to consider this investigation:

• Difficulty urinating or weak urine stream
• Frequent urination, especially at night
• Blood in urine or semen
• Pelvic pain or discomfort
• Bone pain (back, hip, or thigh) — suggestive of bone metastases
• Unexplained weight loss
• Elevated PSA detected on routine blood test
• Abnormal digital rectal examination findings
• Erectile dysfunction with other concerning features

How the this imaging test Procedure Works

The PSMA PET Scan works through molecular targeting. Gallium-68 is chelated to the PSMA-11 (or PSMA-617) ligand — a molecule specifically designed to bind to PSMA protein overexpressed on prostate cancer cells. After intravenous injection, the radiolabelled PSMA ligand circulates through the bloodstream and binds with high affinity to PSMA-expressing cells throughout the body. Normal tissues show minimal PSMA expression (and hence minimal tracer uptake), while prostate cancer cells light up brightly on the PET images.

The PET/CT scanner integrates the functional PET signal (showing cancer cell location and density) with the anatomical CT data (showing organ structure), producing detailed fusion images that give the nuclear medicine physician and treating oncologist a complete picture of disease extent. This dual-modality approach provides the most comprehensive prostate cancer mapping available today.

Preparation Before the the PSMA scan

To ensure the best image quality from your this PET/CT at Neurad Diagnostics in Delhi, follow these preparation guidelines:

• Fasting: Fast for 4–6 hours before the scan. Plain water is permitted and encouraged.
• Hydration: Drink 500 mL of water in the 1 hour before the scan and continue to hydrate well after the procedure.
• Medications: Continue all regular medications including androgen deprivation therapy (ADT) unless otherwise instructed.
• Prior imaging: Bring all prior CT, MRI, bone scan reports, PSA test results, and biopsy/pathology reports.
• Urination: Urinate just before the scan to reduce bladder activity in the pelvic area.
• Clothing: Wear comfortable loose-fitting clothes without metal fastenings.
• Allergies: Inform the team of any known allergies or kidney problems.

Step-by-Step PSMA PET Scan Procedure at Neurad Diagnostics

1. Arrival and registration: Arrive at Neurad Diagnostics at your scheduled time. Our team will review your clinical history and ensure you are properly prepared.
2. IV placement: A small cannula is inserted in your arm for tracer injection.
3. Tracer injection: 68Ga-PSMA tracer is injected intravenously. This is quick, painless, and well-tolerated.
4. Uptake time: You rest in a quiet room for 55–65 minutes for optimal tracer distribution throughout the body.
5. Voiding: You are asked to urinate immediately before the scan begins.
6. Scanning: You lie on the scanner table for approximately 20–30 minutes for image acquisition from skull to mid-thigh.
7. Post-scan care: You may eat and resume activities immediately. Drink plenty of fluids to help clear the tracer.
8. Reporting: Your detailed PSMA PET/CT report is prepared by our expert nuclear medicine physician and delivered promptly.

Advantages of Gallium-68 PSMA Technology

• Detects microscopic disease: Finds prostate cancer spread at sub-centimeter level lymph nodes missed by CT
• Superior to bone scan + CT combined: Single scan replaces multiple conventional imaging tests
• Very low PSA detection: Can detect recurrence at PSA levels as low as 0.2-0.5 ng/mL
• Changes treatment in majority of patients: Leads to major management changes in 50–70% of cases
• PSMA therapy eligibility: Essential for selecting patients for Lu-177 PSMA targeted therapy
• Whole-body imaging in one session: Covers primary site, nodes, bones, and organs simultaneously
• Short procedure time: Completed in 2–3 hours vs. 24–48 hours for older nuclear medicine studies
• Well-tolerated with minimal side effects

Accuracy and Clinical Benefits of the procedure

The this scan has been validated in multiple large prospective clinical trials. The landmark proPSMA trial published in the Lancet (2020) found that PSMA PET/CT had 27% greater accuracy than conventional imaging (CT + bone scan) for staging high-risk prostate cancer before surgery or radiation. The study showed sensitivity of 85% and specificity of 98% for pelvic nodal disease — far surpassing CT’s sensitivity of 38%.

For biochemical recurrence, the OSPREY and CONDOR trials confirmed that PSMA PET Scan detects disease in 55-84% of patients with rising PSA after treatment — findings that directly altered treatment management in the majority of cases. In India, where prostate cancer is increasingly diagnosed in younger men and often at advanced stages, the this imaging test provides a critical diagnostic advantage that can mean the difference between curative and palliative treatment.

Safety Information

The the PSMA scan is extremely safe. Key safety information:

• Low radiation dose: Approximately 3–6 mSv effective dose — comparable to a standard CT abdomen-pelvis
• Short half-life: Gallium-68’s 68-minute half-life means radioactivity clears from the body within hours
• No iodine contrast: No risk of iodine contrast allergy or nephrotoxicity
• Excellent tolerability: Adverse reactions are extremely rare
• AERB-regulated: All procedures at Neurad Diagnostics comply with Indian atomic energy safety regulations

Cost of PSMA PET Scan in Delhi NCR

The cost of this PET/CT in Delhi depends on the equipment quality, tracer availability, and clinical requirements of the patient. At Neurad Diagnostics, we offer this advanced diagnostic service at transparent and competitive pricing. While the investment reflects the advanced technology involved, the the procedure often eliminates the need for multiple conventional imaging studies, providing superior clinical value. Please contact us directly for current PSMA PET Scan pricing in Delhi NCR and any available concessions or packages.

Choosing the Right Center for this scan in Delhi

When looking for the best center for this imaging test near me in Delhi NCR, evaluate these critical factors:

• Availability of Gallium-68 generator/cyclotron for fresh tracer preparation
• Advanced hybrid PET/CT scanner technology
• Experienced nuclear medicine physician team
• AERB licensing and radiation safety compliance
• Rapid, clinically detailed report turnaround
• Track record with prostate cancer imaging
• Clear communication with referring physicians

Why Choose Neurad Diagnostics for PSMA PET Scan in Delhi?

Neurad Diagnostics is Delhi NCR’s specialized Gallium-68 molecular imaging center. We offer PSMA, DOTANOC, FAPI, Exendin, and Trivehexin PET scans alongside CT and USG-guided biopsy services. Our team of nuclear medicine specialists is dedicated to delivering the highest quality prostate cancer imaging to patients across Delhi, Noida, Gurgaon, Faridabad, Ghaziabad, and all of India. We combine cutting-edge technology, clinical expertise, and compassionate patient care to deliver results that make a real difference in your treatment journey.

Frequently Asked Questions About the PSMA scan

1. What does PSMA stand for?

PSMA stands for Prostate-Specific Membrane Antigen — a protein highly expressed on the surface of prostate cancer cells. The this PET/CT targets this protein to detect prostate cancer throughout the body.

2. At what PSA level should I get a PSMA PET Scan?

the procedure can detect disease at PSA levels as low as 0.2 ng/mL. It is recommended for any rising PSA after prostatectomy or radiation, and for initial staging of high-risk prostate cancer regardless of PSA.

3. Is this scan better than bone scan for prostate cancer?

Yes, significantly. PSMA PET Scan detects bone metastases earlier, more accurately, and at smaller sizes than conventional bone scans, while also simultaneously imaging lymph nodes and soft tissue disease.

4. Can this imaging test be used for other cancers?

PSMA expression has been found in some non-prostate cancers including certain types of thyroid cancer, salivary gland tumors, and renal cell carcinoma. However, it is primarily used for prostate cancer imaging.

5. Does PSMA PET replace biopsy?

No. the PSMA scan is an imaging study and does not replace tissue biopsy for definitive diagnosis. However, it can guide targeted biopsy of suspicious lesions and provide critical staging information before treatment decisions.

6. How is 68Ga-PSMA different from F-18 PSMA?

Both are PSMA-targeted PET tracers. Gallium-68 PSMA uses a generator-produced isotope while F-18 PSMA (like PYLARIFY) uses a cyclotron-produced isotope with a slightly longer half-life. Both have excellent diagnostic performance for prostate cancer.

7. Will I be radioactive after the PSMA PET Scan?

The radioactivity from Gallium-68 clears very rapidly due to its short 68-minute half-life. Within a few hours after the scan, radiation levels are negligible. Brief precautionary distancing from small children and pregnant women for the remainder of the scan day is recommended.

8. How quickly can I get this PET/CT results?

At Neurad Diagnostics, we provide detailed the procedure reports promptly after the procedure. Our nuclear medicine physicians prepare comprehensive reports that your urologist or oncologist can use for immediate treatment planning.

9. Is PSMA PET Scan covered by insurance in India?

Insurance coverage for this scan is evolving in India. We recommend checking with your insurance provider. Neurad Diagnostics can provide necessary documentation to support insurance claims.

10. Where is the best this imaging test center in Delhi NCR?

Neurad Diagnostics is a leading specialized center for PSMA PET Scan in Delhi NCR, offering Gallium-68 molecular imaging with experienced nuclear medicine physicians and state-of-the-art technology.

Conclusion — Book Your the PSMA scan at Neurad Diagnostics Delhi Today

A this PET/CT is a transformative diagnostic tool for prostate cancer patients. Its ability to detect disease at the molecular level — far beyond what conventional imaging can achieve — means better staging, more targeted treatment, and improved outcomes. If you have been diagnosed with prostate cancer, or if your PSA is rising after treatment, do not settle for less than the most accurate imaging available. Get your PSMA PET Scan in Delhi at Neurad Diagnostics today.